This story is about the microbial theory of Alzheimer’s disease. Why am I writing about it? I am writing about it because it’s like unraveling a detective plot. There is a disease that they say a lot of people have — and that is caused, they say, by amyloid deposits in the brain. But then… Read More »
Fluorinated chemicals known as polyfluoroalkyl or perfluoroalkyl chemicals (PFASs), which include PFOA and PFOS, can be found in most Americans.1 The widely used chemicals have been added to industry and consumer products since the 1940s, but while PFOA and PFOS have been phased out in the U.S. due to their toxic properties, other PFAS are… Read More »
A collaborative group of researchers has identified substantial microbial changes in the intestines of at-risk infants before disease onset in a new, long-term, prospective approach to the development of celiac disease. Using advanced genomic sequencing techniques, MassGeneral Hospital for Children (MGHfC) researchers, along with colleagues from institutions in Italy and the University of Maryland, College… Read More »
By STEVEN ZECOLA If asked, the leaders of the research organizations working on Parkinson’s disease would say that they have made tremendous progress and are optimistic on finding a cure for the disease. In truth, this viewpoint understates the magnitude of the challenge and results in insufficient resources being devoted to PD. Given the size… Read More »
Motor neurone disease has dogged my medical career. As a student taking medical finals, one of the patients I was tested on had a particular form of MND, amyotrophic lateral sclerosis, and I’ve never forgotten it. Then, in middle age, a friend told me he had MND and I watched him, over a couple of… Read More »
FDA Approves Kerendia (finerenone) for the Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes WHIPPANY, N.J.– July 9, 2021 (BUSINESS WIRE)– Bayer announced today the United States (U.S.) Food and Drug Administration (FDA) has approved Kerendia (finerenone), a first-in-class nonsteroidal mineralocorticoid receptor antagonist (MRA) indicated to reduce the risk of sustained… Read More »
Drinking moderate amounts of alcohol may help protect the heart by dampening stress-related signals in the brain, research suggests. S scientists found that when compared to being teetotal or indulging in excessive levels of alcohol, moderate drinking – equivalent to one drink for women and two for men per day – is associated with a… Read More »